• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活物受体基因表达在癌症侵袭和转移中的作用及调控

The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.

作者信息

Wang Y

机构信息

Orthopaedic Research Institute, St George Hospital, University of New South Wales, Sydney, NSW 2145, Australia.

出版信息

Med Res Rev. 2001 Mar;21(2):146-70. doi: 10.1002/1098-1128(200103)21:2<146::aid-med1004>3.0.co;2-b.

DOI:10.1002/1098-1128(200103)21:2<146::aid-med1004>3.0.co;2-b
PMID:11223863
Abstract

This article reviews the role of urokinase-type plasminogen activator receptor (uPAR) and its protein, mRNA, cDNA, genomic organization, promoter, transcription activation factors, and signal transduction. The uPAR has been implicated in several biological processes including angiogenesis, monocyte migration, cancer metastasis, trophoblast implantation, and wound healing. It is a specific cell surface receptor for its ligand uPA which catalyzes the formation of plasmin from plasminogen to generate the proteolytic cascade that contributes to the breakdown of extracellular matrix, a key step in cancer metastasis. The uPAR is a 55-60 kDa glycoprotein organized as three homologous cysteine-rich domains. It attaches to the plasma membrane via a covalent linkage to a glycosyl-phosphatidylinositol (GPI) moiety and appears to play an important role in transmembrane signalling. The 1.4-kb human uPAR cDNA and 21.23-kb genomic DNA have been cloned and the gene contains seven exons. The uPAR promoter region was defined in a 188 bp fragment between bases -141 and +47 relative to the transcription start site. Binding of transcription factors (Sp1, AP-2, NFkappaB and two AP-1) to the uPAR promoter region activates the basal transcription of the gene. There is a strong correlation between uPAR expression and the invasive cancer cell phenotype. uPAR may play a critical role in the process of cancer invasion and metastasis, as antisense uPAR mRNA can inhibit cancer spread in vitro and in vivo. These studies may provide a novel therapeutic target for blocking cancer invasion and metastasis.

摘要

本文综述了尿激酶型纤溶酶原激活物受体(uPAR)及其蛋白、mRNA、cDNA、基因组结构、启动子、转录激活因子和信号转导的作用。uPAR参与了包括血管生成、单核细胞迁移、癌症转移、滋养层植入和伤口愈合在内的多种生物学过程。它是其配体uPA的特异性细胞表面受体,uPA催化纤溶酶原形成纤溶酶,从而产生蛋白水解级联反应,这是癌症转移的关键步骤,有助于细胞外基质的分解。uPAR是一种55 - 60 kDa的糖蛋白,由三个富含半胱氨酸的同源结构域组成。它通过与糖基磷脂酰肌醇(GPI)部分的共价连接附着于质膜,似乎在跨膜信号传导中起重要作用。1.4 kb的人uPAR cDNA和21.23 kb的基因组DNA已被克隆,该基因包含七个外显子。uPAR启动子区域在相对于转录起始位点的 - 141至 + 47碱基之间的188 bp片段中被确定。转录因子(Sp1、AP - 2、NFκB和两个AP - 1)与uPAR启动子区域的结合激活了该基因的基础转录。uPAR表达与侵袭性癌细胞表型之间存在很强的相关性。uPAR可能在癌症侵袭和转移过程中起关键作用,因为反义uPAR mRNA可以在体外和体内抑制癌症扩散。这些研究可能为阻断癌症侵袭和转移提供一个新的治疗靶点。

相似文献

1
The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.尿激酶型纤溶酶原激活物受体基因表达在癌症侵袭和转移中的作用及调控
Med Res Rev. 2001 Mar;21(2):146-70. doi: 10.1002/1098-1128(200103)21:2<146::aid-med1004>3.0.co;2-b.
2
cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.尿激酶氨基末端片段的cDNA转染有效抑制癌细胞侵袭和转移。
DNA Cell Biol. 2001 May;20(5):297-305. doi: 10.1089/104454901750232490.
3
Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.
Front Biosci. 1999 Feb 15;4:D178-87. doi: 10.2741/mohanam.
4
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].肿瘤细胞诱导的细胞外基质降解机制——抑制细胞表面蛋白水解活性可能对肿瘤细胞侵袭和转移具有治疗作用
Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32.
5
Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells.抗尿激酶型纤溶酶原激活物受体脱氧核酶对骨肉瘤细胞尿激酶受体基因表达及细胞侵袭的抑制作用
FEBS J. 2005 Jul;272(14):3572-82. doi: 10.1111/j.1742-4658.2005.04778.x.
6
Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.被占据的尿激酶受体(uPAR)与低密度脂蛋白受体相关蛋白的直接结合是uPAR内吞作用和细胞表面尿激酶活性调节所必需的。
Mol Biol Cell. 2001 May;12(5):1467-79. doi: 10.1091/mbc.12.5.1467.
7
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.乳腺癌中的尿激酶型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂受体
Int J Cancer. 1995 May 29;61(5):597-600. doi: 10.1002/ijc.2910610502.
8
Regulation and role of urokinase plasminogen activator in vascular remodelling.尿激酶型纤溶酶原激活剂在血管重塑中的调节作用
Clin Exp Pharmacol Physiol. 1996 Sep;23(9):759-65. doi: 10.1111/j.1440-1681.1996.tb01177.x.
9
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.尿激酶型纤溶酶原激活物受体(uPAR)在血液和骨髓细胞上的结构、功能及表达
Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398.
10
Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.三种人乳腺癌细胞系中的尿激酶型纤溶酶原激活与其体外侵袭性相关。
Clin Exp Metastasis. 1996 May;14(3):297-307. doi: 10.1007/BF00053903.

引用本文的文献

1
Endothelial-specific Enhancer as a Cis Element of Regulation by TNF-alpha, IL-1beta, and VEGF.内皮细胞特异性增强子作为 TNF-α、IL-1β 和 VEGF 调节的顺式元件。
Curr Pharm Des. 2024;30(21):1630-1640. doi: 10.2174/0113816128296376240424072322.
2
Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma.构建和验证一种新型的肺腺癌中性粒细胞相关基因特征的预后模型。
Sci Rep. 2023 Oct 25;13(1):18226. doi: 10.1038/s41598-023-45289-8.
3
Identification of PLAUR-related ceRNA and immune prognostic signature for kidney renal clear cell carcinoma.
肾透明细胞癌中PLAUR相关ceRNA的鉴定及免疫预后特征
Front Oncol. 2022 Aug 16;12:834524. doi: 10.3389/fonc.2022.834524. eCollection 2022.
4
The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.尿激酶受体(uPAR)作为靶向癌症治疗中的“特洛伊木马”:挑战与机遇
Cancers (Basel). 2021 Oct 27;13(21):5376. doi: 10.3390/cancers13215376.
5
GLIPR1 Protects Against Cigarette Smoke-Induced Airway Inflammation via PLAU/EGFR Signaling.GLIPR1 通过 PLAU/EGFR 信号通路保护气道免受香烟烟雾诱导的炎症反应。
Int J Chron Obstruct Pulmon Dis. 2021 Oct 8;16:2817-2832. doi: 10.2147/COPD.S328313. eCollection 2021.
6
Plau and Tgfbr3 are YAP-regulated genes that promote keratinocyte proliferation.Plau 和 Tgfbr3 是 YAP 调节的基因,可促进角质形成细胞增殖。
Cell Death Dis. 2018 Oct 31;9(11):1106. doi: 10.1038/s41419-018-1141-5.
7
Anti-cancer effect of Aquaporin 5 silencing in colorectal cancer cells in association with inhibition of Wnt/β-catenin pathway.水通道蛋白5沉默通过抑制Wnt/β-连环蛋白信号通路对结肠癌细胞产生抗癌作用。
Cytotechnology. 2018 Apr;70(2):615-624. doi: 10.1007/s10616-017-0147-7. Epub 2018 Feb 17.
8
Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.用于靶向前列腺癌中尿激酶型纤溶酶原激活物受体(uPAR)的异硫氰酸酯功能化双功能螯合物及面式-[M(I)(CO)3](+)(M = Re、(99m)Tc)配合物
Bioconjug Chem. 2016 Jan 20;27(1):130-42. doi: 10.1021/acs.bioconjchem.5b00531. Epub 2015 Dec 30.
9
Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.骨肉瘤从非转移表型向转移表型的进展与自分泌和旁分泌尿激酶型纤溶酶原激活物(uPA)轴的激活存在因果关联。
PLoS One. 2015 Aug 28;10(8):e0133592. doi: 10.1371/journal.pone.0133592. eCollection 2015.
10
FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.FOXM1c通过上调尿激酶型纤溶酶原激活系统的表达促进胰腺癌上皮-间质转化和转移。
Clin Cancer Res. 2014 Mar 15;20(6):1477-88. doi: 10.1158/1078-0432.CCR-13-2311. Epub 2014 Jan 22.